1. Home
  2. AXR vs RANI Comparison

AXR vs RANI Comparison

Compare AXR & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMREP Corporation

AXR

AMREP Corporation

HOLD

Current Price

$25.07

Market Cap

131.8M

Sector

Real Estate

ML Signal

HOLD

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

HOLD

Current Price

$1.09

Market Cap

126.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXR
RANI
Founded
1961
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Medicinal Chemicals and Botanical Products
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
131.8M
126.8M
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
AXR
RANI
Price
$25.07
$1.09
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$30.00
$7.50
AVG Volume (30 Days)
6.9K
752.9K
Earning Date
03-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
89.60
57.14
EPS
1.68
N/A
Revenue
$12,831,000.00
$1,633,000.00
Revenue This Year
$10.12
$274.77
Revenue Next Year
N/A
$79.44
P/E Ratio
$14.64
N/A
Revenue Growth
N/A
58.85
52 Week Low
$17.61
$0.39
52 Week High
$29.00
$3.87

Technical Indicators

Market Signals
Indicator
AXR
RANI
Relative Strength Index (RSI) 38.49 59.26
Support Level $24.12 $1.07
Resistance Level $28.81 $1.22
Average True Range (ATR) 0.73 0.07
MACD -0.36 0.03
Stochastic Oscillator 16.29 82.25

Price Performance

Historical Comparison
AXR
RANI

About AXR AMREP Corporation

Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: